TABLE 3
Whole-Body Patient Dosimetry Results
| No. of VSVs | |||||||
| Site | 1 | 4 | 6 | 8 | 10 | 20 | Organ-based approach |
| Gallbladder wall | −0.03 | 0.24 | 0.60 | 0.60 | 0.57 | 0.49 | 7.24 |
| Heart wall | −3.96 | −0.23 | 1.08 | 0.91 | 0.11 | −0.24 | 38.54 |
| Kidney | 1.78 | 1.78 | 2.40 | 2.40 | 2.40 | 2.40 | −3.86 |
| Liver | 1.41 | 1.58 | 1.65 | 1.69 | 1.63 | 1.45 | −18.08 |
| Lung | −52.85 | 16.28 | 16.72 | 7.64 | 4.29 | 0.53 | 23.43 |
| Pancreas | 1.08 | 1.18 | 1.37 | 1.37 | 1.36 | 1.35 | 1707.15 |
| Spleen | 1.50 | 1.76 | 2.05 | 2.14 | 2.01 | 1.94 | 25.07 |
| Stomach wall | −2.60 | −0.18 | 0.66 | 0.65 | 0.25 | −0.29 | 40.16 |
| Average | −6.71 | −2.80 | −3.32 | 2.17 | 1.58 | 0.95 | 227.46 |
| Average (excluding Pancreas) | −7.82 | 3.03 | 3.60 | 2.29 | 1.61 | 0.90 | 16.07 |
Data are organ dose percentage difference
.
